Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion type Assertion NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_head.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion description "[Erythropoietin (EPO) is of great interest as a therapy for many of the central nervous system (CNS) diseases and its administration is protective in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion evidence source_evidence_literature NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion SIO_000772 18670620 NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion wasDerivedFrom befree-20140225 NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.
- NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_assertion wasGeneratedBy ECO_0000203 NP414539.RAzw6uUKmg4tUBMJVovvhZzEwLmt5vSWj3ox2cF8EibHo130_provenance.